Acxiom Corporation (NASDAQ:ACXM) (Reuters)
(Reuters) – Shares of Acxiom Corp (ACXM.O) plunged as much as 34 percent on Thursday, after Facebook Inc (FB.O) said it would end its partnerships with several large data brokers who help advertisers target people on the social network. The stock has now lost nearly half of its market value since Facebook’s comments on Wednesday that added to fears of increased scrutiny around how public data is handled and shared. Facebook is under pressure to improve how it manages data after disclosing that information on about 50 million Facebook users wrongly ended up in the hands of political consultancy Cambridge Analytica.
GameStop Corp. (NYSE:GME) (The Motley Fool)
What happened: Shares of GameStop (NYSE:GME) tumbled on Thursday following the video game retailer’s fourth-quarter report. While GameStop posted impressive comparable sales growth and beat analyst estimates across the board, a massive write-off related to its technology brands business and lackluster guidance overshadowed those positives. The stock was down about 9% at 12:10 p.m. EDT, and it was down as much as 13.8% earlier in the day.
Bloomua/Shutterstock.com
Galectin Therapeutics Inc. (NASDAQ:GALT) (Benzinga)
Galectin Therapeutics, Inc. (NASDAQ: GALT) shares surged 20.6 percent to $4.56. Galectin Therapeutics posted a FY17 loss of $0.49 per share and disclosed that it continues to remain in ongoing discussions with a number of pharma companies about potential partnerships.
Verint Systems Inc. (NASDAQ:VRNT) (CNBC)
Verint Systems – Verint reported adjusted quarterly profit of $1.05 per share, 5 cents a share above estimates. Revenue also topped consensus. The maker of customer engagement and security software also raised its full-year outlook.
Movado Group, Inc (NYSE:MOV) (The Motley Fool)
What happened: Shares of Movado Group Inc. (NYSE:MOV) were up 15.8% as of 1 p.m. EDT Thursday, after the Swiss watchmaker announced stronger-than-expected fiscal fourth-quarter 2018 results and boosted its dividend. Movado’s quarterly revenue grew 14.1% year over year (or 10.2% at constant currencies) to $149.2 million, well above the $132.5 million investors were expecting.
PVH Corp (NYSE:PVH) (CNBC)
PVH – PVH reported adjusted quarterly profit of $1.58 per share, 11 cents a share ahead of consensus forecasts. Revenue also beat estimates and the apparel maker gave upbeat 2018 guidance as sales of its Tommy Hilfiger and Calvin Klein brands remain strong.
MediciNova, Inc. (NASDAQ:MNOV) (Benzinga)
MediciNova, Inc. declined 13.3 percent to $10.37 after the company disclosed that its Phase 2 clinical trial of MN-166 did not meet primary endpoint.
Constellation Brands, Inc. (NYSE:STZ) (MarketWatch)
Shares of Constellation Brands Inc. STZ, +3.73% shot up 3.4% in premarket trade Thursday, after the alcoholic beverage company reported fiscal fourth-quarter profit and sales that beat expectations, and boosted its dividend by 42%. Net income for the quarter to Feb. 28 rose to $925.5 million, or $4.64 a share, from $452.0 million, or $2.26 a share, in the same period a year ago.
Takeda Pharmaceutical Co Ltd (ADR) (OTCMKTS:TKPYY) (The Wall Street Journal)
TOKYO- Takeda Pharmaceutical Co. TKPYY -4.94% shares fell 7.4% on Thursday to their lowest level in more than a year, over concerns that the potential of a blockbuster deal to acquire Shire PLC was too much for the Japanese company to swallow. Takeda said Wednesday it was weighing a bid for Western rival Shire, raising the prospect of a combination that would create a global top-10 drug maker with a market value of more than $80 billion. It called the study “exploratory” and said it would decide by April 25 whether to go through with such a bid.
